January 10, 2022
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021
MARLBOROUGH, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2021. Akoya reported the following preliminary financial...

Continue Reading
January 5, 2022
Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
Akoya’s powerful new PhenoCycler™-Fusion system combined with Bio-Techne’s proven and established RNAScope® technology will enable comprehensive spatial phenotyping of RNA and protein biomarkers MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ:...

Continue Reading
January 4, 2022
Akoya Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
MARLBOROUGH, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be virtually participating in the 40 th Annual J.P. Morgan Healthcare Conference. Brian McKelligon, CEO, is scheduled to present on...

Continue Reading
Displaying 11 - 13 of 13

Search Investor Relations